🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2015-11-02
Trial ID
NCT02429843
Treatments Being Tested
This is a study of TRC105 in combination with standard dose pazopanib compa...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2017-02-13
Trial ID
NCT02979899
Background: \- Glioblastoma is an aggressive type of brain cancer that oft...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-12
Trial ID
NCT01778530
Treatments Being Tested
The purpose of the study is to determine the overall response rate of singl...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2016-03
Trial ID
NCT02664961
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of TRC105 ...
Status
Completed
Location
University of Cincinnati
Start Date
2012-05
Trial ID
NCT01564914
Treatments Being Tested
This study will test how well a new combination of three drugs (Letrozole, ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-02-01
Trial ID
NCT02520063
Treatments Being Tested
Background: * Currently, there is no curative therapy for metastatic castr...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-02-23
Trial ID
NCT01090765
Treatments Being Tested
Phase 1b: To evaluate safety and tolerability and determine a recommended p...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-08
Trial ID
NCT01806064
Treatments Being Tested
This research study is being done to measure the clinical benefit of TRC105...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2018-03-05
Trial ID
NCT03418324
Treatments Being Tested
The purpose of this study is to examine the combination of osimertinib and ...
Status
Recruiting
Location
Cedars-Sinai Cancer at Beverly Hills (THO)
Start Date
2023-09-15
Trial ID
NCT05401110
Treatments Being Tested